Tech Center 1600 • Art Units: 1611
This examiner grants 35% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17047195 | ROS-RESPONSIVE MICRONEEDLE PATCH FOR ACNE VULGARIS TREATMENT | Final Rejection | North Carolina State University |
| 18084402 | COMPOSITIONS AND METHODS FOR REMOVING COLOR FROM HAIR | Non-Final OA | L'Oreal |
| 17731759 | COMPOSITIONS SUITABLE AS SETTERS | Non-Final OA | L'OREAL |
| 17731791 | COMPOSITIONS SUITABLE AS SETTERS | Non-Final OA | L'OREAL |
| 16954238 | COLOURED AQUEOUS PARTICLE DISPERSION COMPRISING AT LEAST ONE PARTICULATE DYESTUFF, A MATT-EFFECT FILLER, FILM-FORMING POLYMER PARTICLES, A THICKENER AND AN IONIC POLYMERIC DISPERSANT | Final Rejection | L'OREAL |
| 17608538 | Complex of Noble Metal Oxide Nanoparticles and Tellurium Nanowires and Biomedical Applications Thereof | Final Rejection | Northeastern University |
| 17999061 | FORMULATION CONTAINING IBUPROFEN | Final Rejection | RECKITT BENCKISER HEALTH LIMITED |
| 18250782 | MODIFIED RELEASE COMPOSITIONS COMPRISING MELATONIN | Non-Final OA | NUTRIVENTIA PRIVATE LIMITED |
| 18033005 | CANNABIDIOL-CONTAINING SEAMLESS SOFT CAPSULE | Final Rejection | Fuji Capsule Co., LTD. |
| 18021647 | NANO LIPID CARRIER SYSTEM FOR IMPROVING PERMEATION OF ACTIVE INGREDIENTS | Non-Final OA | LEIUTIS PHARMACEUTICALS LLP |
| 17268657 | TREATMENT OF HEPATITIS DELTA VIRUS INFECTION WITH INTERFERON LAMBDA | Non-Final OA | EIT Pharma, Inc. |
| 17253077 | LOADABLE POROUS STRUCTURES FOR USE AS IMPLANTS | Non-Final OA | FEDSON, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy